Back
Janux Therapeutics Stock Price Chart
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
JANX
Janux Therapeutics
Last Price:
50.18
Seasonality Move:
-11.26%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing slight buying pressure.
Janux Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.92 | Buy |
| 20-day SMA: | 45.86 | Buy |
| 50-day SMA: | 43.34 | Buy |
| 200-day SMA: | 34.63 | Buy |
| 8-day EMA: | 48.05 | Buy |
| 20-day EMA: | 46.01 | Buy |
| 50-day EMA: | 44.23 | Buy |
| 200-day EMA: | 36.24 | Buy |
Janux Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.8 | Buy |
| Relative Strength Index (14 RSI): | 62.28 | Buy |
| Chaikin Money Flow: | 141306 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.74 - 47.92) | Buy |
| Bollinger Bands (100): | (39.33 - 50.89) | Buy |
Janux Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 50.03 while JANX 8-day simple moving average is 47.92, which is a Buy signal.
- The stock price of JANX is 50.03 while Janux Therapeutics 20-day SMA is 45.86, which makes it a Buy.
- Janux Therapeutics 50-day simple moving average is 43.34 while JANX share price is 50.03, making it a Buy technically.
- JANX stock price is 50.03 and Janux Therapeutics 200-day simple moving average is 34.63, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a Sell
The current Janux Therapeutics [JANX] share price is $50.03. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
2.61B
Price in USD:
50.03
Share Volume:
672.62K
Janux Therapeutics 52-Week Range
52-Week High:
65.60
52-Week Low:
5.65
Sell
34
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?
The Janux Therapeutics stock price is 50.03 USD today. -
Will JANX stock go up or go down?
Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Janux Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 50.03 while JANX 8-day exponential moving average is 48.05, which is a Buy signal.
- The stock price of JANX is 50.03 while Janux Therapeutics 20-day EMA is 46.01, which makes it a Buy.
- Janux Therapeutics 50-day exponential moving average is 44.23 while JANX share price is 50.03, making it a Buy technically.
- JANX stock price is 50.03 and Janux Therapeutics 200-day simple moving average is 36.24, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.19 per share, and a decrease next year of $0.46 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
- JANX Moving Average Covergence Divergence (MACD) indicator is 1.8, suggesting Janux Therapeutics is a Buy
- Janux Therapeutics Relative Strength Index (RSI) is 62.28, which suggest Janux Therapeutics is overbought
- The Bollinger Bands (25) for Janux Therapeutics is (42.74 - 47.92), which suggest Janux Therapeutics is a Buy
- The Bollinger Bands (100) for Janux Therapeutics is (39.33 - 50.89), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.